125 related articles for article (PubMed ID: 17569169)
1. Drug profile: telbivudine (Tyzeka).
Pham PA; Thio C
Hopkins HIV Rep; 2007 Jan; 19(1):7, 10. PubMed ID: 17569169
[No Abstract] [Full Text] [Related]
2. Telbivudine (Tyzeka) for chronic Hepatitis B.
Med Lett Drugs Ther; 2007 Jan; 49(1253):11-2. PubMed ID: 17261968
[No Abstract] [Full Text] [Related]
3. A review of telbivudine for the management of chronic hepatitis B virus infection.
Lui YY; Chan HL
Expert Opin Drug Metab Toxicol; 2008 Oct; 4(10):1351-61. PubMed ID: 18798704
[TBL] [Abstract][Full Text] [Related]
4. Treatment of chronic hepatitis B: focus on telbivudine.
Lui YY; Chan HL
Expert Rev Anti Infect Ther; 2009 Apr; 7(3):259-68. PubMed ID: 19344240
[TBL] [Abstract][Full Text] [Related]
5. Safety evaluation of telbivudine.
But DY; Yuen MF; Fung J; Lai CL
Expert Opin Drug Saf; 2010 Sep; 9(5):821-9. PubMed ID: 20662545
[TBL] [Abstract][Full Text] [Related]
6. Treatment of chronic hepatitis B with telbivudine: wise hepatologists needed in hepatitis B endemic countries where treatment options are limited.
Yurdaydin C; Akarca US
Liver Int; 2011 May; 31(5):589-91. PubMed ID: 21457431
[No Abstract] [Full Text] [Related]
7. [Telbivudine in the treatment of the chronic B hepatitis].
Butà MA
Gastroenterol Hepatol; 2008 Apr; 31(4):258-63. PubMed ID: 18405491
[No Abstract] [Full Text] [Related]
8. Telbivudine: a novel nucleoside analog for chronic hepatitis B.
Kim JW; Park SH; Louie SG
Ann Pharmacother; 2006 Mar; 40(3):472-8. PubMed ID: 16507625
[TBL] [Abstract][Full Text] [Related]
9. Pharmacokinetics of telbivudine following oral administration of escalating single and multiple doses in patients with chronic hepatitis B virus infection: pharmacodynamic implications.
Zhou XJ; Lim SG; Lloyd DM; Chao GC; Brown NA; Lai CL
Antimicrob Agents Chemother; 2006 Mar; 50(3):874-9. PubMed ID: 16495245
[TBL] [Abstract][Full Text] [Related]
10. Summaries for patients. Antiviral therapy for chronic hepatitis B.
Ann Intern Med; 2007 Dec; 147(11):I16. PubMed ID: 17909200
[No Abstract] [Full Text] [Related]
11. Telbivudine: a new option for the treatment of chronic hepatitis B.
Ruiz-Sancho A; Sheldon J; Soriano V
Expert Opin Biol Ther; 2007 May; 7(5):751-61. PubMed ID: 17477811
[TBL] [Abstract][Full Text] [Related]
12. Telbivudine versus lamivudine in patients with chronic hepatitis B.
Tillmann HL; McHutchison JG
N Engl J Med; 2008 Apr; 358(14):1517; author reply 1517-8. PubMed ID: 18385505
[No Abstract] [Full Text] [Related]
13. Telbivudine: rhabdomyolysis and neuropathy.
Prescrire Int; 2010 Aug; 19(108):171. PubMed ID: 20941856
[No Abstract] [Full Text] [Related]
14. [Telbivudine in the management of HIV/HBV coinfection. Treating hepatitis B without HIV trouble].
MMW Fortschr Med; 2009 Apr; 151(18):62-3. PubMed ID: 19769080
[No Abstract] [Full Text] [Related]
15. [Efficacy and safety of telbivudine in pregnant chronic hepatitis B patients].
Zhou YJ; Zheng JL; Pan HJ; Jiang S
Zhonghua Gan Zang Bing Za Zhi; 2011 Nov; 19(11):861-2. PubMed ID: 22553840
[No Abstract] [Full Text] [Related]
16. Telbivudine: a new treatment for chronic hepatitis B.
Amarapurkar DN
World J Gastroenterol; 2007 Dec; 13(46):6150-5. PubMed ID: 18069753
[TBL] [Abstract][Full Text] [Related]
17. [New treatment of chronic hepatitis B].
Andersen ES; Weis NM
Ugeskr Laeger; 2008 Nov; 170(48):3937-9. PubMed ID: 19087730
[TBL] [Abstract][Full Text] [Related]
18. Telbivudine: an effective anti-HBV drug for chronic hepatitis B patients with early on-treatment responses.
Hann HW
Expert Opin Pharmacother; 2010 Sep; 11(13):2243-9. PubMed ID: 20698726
[TBL] [Abstract][Full Text] [Related]
19. Telbivudine versus lamivudine in patients with chronic hepatitis B.
Lai CL; Gane E; Liaw YF; Hsu CW; Thongsawat S; Wang Y; Chen Y; Heathcote EJ; Rasenack J; Bzowej N; Naoumov NV; Di Bisceglie AM; Zeuzem S; Moon YM; Goodman Z; Chao G; Constance BF; Brown NA;
N Engl J Med; 2007 Dec; 357(25):2576-88. PubMed ID: 18094378
[TBL] [Abstract][Full Text] [Related]
20. A 24-week, parallel-group, open-label, randomized clinical trial comparing the early antiviral efficacy of telbivudine and entecavir in the treatment of hepatitis B e antigen-positive chronic hepatitis B virus infection in adult Chinese patients.
Zheng MH; Shi KQ; Dai ZJ; Ye C; Chen YP
Clin Ther; 2010 Apr; 32(4):649-58. PubMed ID: 20435234
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]